National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank

Mark A Frye, Allen Doederlein, Barbara Koenig, Susan L. Mcelroy, Malik Nassan, Lisa R. Seymour, Joanna M Biernacka, Allen S. Daniels

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: The aim of the present study was to engage a national advocacy group and local stakeholders for guidance in developing a bipolar disorder biobank through a web-based survey and a community advisory board. Methods: The Depression and Bipolar Support Alliance and the Mayo Clinic Bipolar Biobank conducted a national web-based survey inquiring about interest in participating in a biobank (i.e., giving DNA and clinical information). A community advisory board was convened to guide establishment of the biobank and identify key deliverables from the research project and for the community. Results: Among 385 survey respondents, funding source (87%), professional opinion (76%), mental health consumer opinion (79%), and return of research results (91%) were believed to be important for considering study participation. Significantly more patients were willing to participate in a biobank managed by a university or clinic (78.2%) than one managed by government (63.4%) or industry (58.2%; both p < 0.001). The nine-member community advisory board expressed interest in research to help predict the likelihood of bipolar disorder developing in a child of an affected parent and which medications to avoid. The advisory board endorsed the use of a comprehension questionnaire to evaluate participants' understanding of the study (e.g., longevity of DNA specimens, right to remove samples, accessing medical records) as a means to strengthen the informed consent process. Conclusions: These national survey and community advisory data support the merit of establishing a biobank to enable studies of disease risk, provided that health records and research results are adequately protected. The goals of earlier diagnosis and individualized treatment of bipolar disorder were endorsed.

Original languageEnglish (US)
Pages (from-to)598-605
Number of pages8
JournalBipolar Disorders
Volume17
Issue number6
DOIs
StatePublished - Sep 1 2015

Fingerprint

Bipolar Disorder
Research
DNA
Informed Consent
Medical Records
Surveys and Questionnaires
Early Diagnosis
Industry
Mental Health
Health

Keywords

  • Biobank
  • Bipolar disorder
  • Phenotype

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Frye, M. A., Doederlein, A., Koenig, B., Mcelroy, S. L., Nassan, M., Seymour, L. R., ... Daniels, A. S. (2015). National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank. Bipolar Disorders, 17(6), 598-605. https://doi.org/10.1111/bdi.12322

National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank. / Frye, Mark A; Doederlein, Allen; Koenig, Barbara; Mcelroy, Susan L.; Nassan, Malik; Seymour, Lisa R.; Biernacka, Joanna M; Daniels, Allen S.

In: Bipolar Disorders, Vol. 17, No. 6, 01.09.2015, p. 598-605.

Research output: Contribution to journalArticle

Frye, MA, Doederlein, A, Koenig, B, Mcelroy, SL, Nassan, M, Seymour, LR, Biernacka, JM & Daniels, AS 2015, 'National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank', Bipolar Disorders, vol. 17, no. 6, pp. 598-605. https://doi.org/10.1111/bdi.12322
Frye MA, Doederlein A, Koenig B, Mcelroy SL, Nassan M, Seymour LR et al. National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank. Bipolar Disorders. 2015 Sep 1;17(6):598-605. https://doi.org/10.1111/bdi.12322
Frye, Mark A ; Doederlein, Allen ; Koenig, Barbara ; Mcelroy, Susan L. ; Nassan, Malik ; Seymour, Lisa R. ; Biernacka, Joanna M ; Daniels, Allen S. / National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank. In: Bipolar Disorders. 2015 ; Vol. 17, No. 6. pp. 598-605.
@article{3f53125f1e254cb78183a30ca08f925e,
title = "National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank",
abstract = "Objectives: The aim of the present study was to engage a national advocacy group and local stakeholders for guidance in developing a bipolar disorder biobank through a web-based survey and a community advisory board. Methods: The Depression and Bipolar Support Alliance and the Mayo Clinic Bipolar Biobank conducted a national web-based survey inquiring about interest in participating in a biobank (i.e., giving DNA and clinical information). A community advisory board was convened to guide establishment of the biobank and identify key deliverables from the research project and for the community. Results: Among 385 survey respondents, funding source (87{\%}), professional opinion (76{\%}), mental health consumer opinion (79{\%}), and return of research results (91{\%}) were believed to be important for considering study participation. Significantly more patients were willing to participate in a biobank managed by a university or clinic (78.2{\%}) than one managed by government (63.4{\%}) or industry (58.2{\%}; both p < 0.001). The nine-member community advisory board expressed interest in research to help predict the likelihood of bipolar disorder developing in a child of an affected parent and which medications to avoid. The advisory board endorsed the use of a comprehension questionnaire to evaluate participants' understanding of the study (e.g., longevity of DNA specimens, right to remove samples, accessing medical records) as a means to strengthen the informed consent process. Conclusions: These national survey and community advisory data support the merit of establishing a biobank to enable studies of disease risk, provided that health records and research results are adequately protected. The goals of earlier diagnosis and individualized treatment of bipolar disorder were endorsed.",
keywords = "Biobank, Bipolar disorder, Phenotype",
author = "Frye, {Mark A} and Allen Doederlein and Barbara Koenig and Mcelroy, {Susan L.} and Malik Nassan and Seymour, {Lisa R.} and Biernacka, {Joanna M} and Daniels, {Allen S.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1111/bdi.12322",
language = "English (US)",
volume = "17",
pages = "598--605",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "6",

}

TY - JOUR

T1 - National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank

AU - Frye, Mark A

AU - Doederlein, Allen

AU - Koenig, Barbara

AU - Mcelroy, Susan L.

AU - Nassan, Malik

AU - Seymour, Lisa R.

AU - Biernacka, Joanna M

AU - Daniels, Allen S.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Objectives: The aim of the present study was to engage a national advocacy group and local stakeholders for guidance in developing a bipolar disorder biobank through a web-based survey and a community advisory board. Methods: The Depression and Bipolar Support Alliance and the Mayo Clinic Bipolar Biobank conducted a national web-based survey inquiring about interest in participating in a biobank (i.e., giving DNA and clinical information). A community advisory board was convened to guide establishment of the biobank and identify key deliverables from the research project and for the community. Results: Among 385 survey respondents, funding source (87%), professional opinion (76%), mental health consumer opinion (79%), and return of research results (91%) were believed to be important for considering study participation. Significantly more patients were willing to participate in a biobank managed by a university or clinic (78.2%) than one managed by government (63.4%) or industry (58.2%; both p < 0.001). The nine-member community advisory board expressed interest in research to help predict the likelihood of bipolar disorder developing in a child of an affected parent and which medications to avoid. The advisory board endorsed the use of a comprehension questionnaire to evaluate participants' understanding of the study (e.g., longevity of DNA specimens, right to remove samples, accessing medical records) as a means to strengthen the informed consent process. Conclusions: These national survey and community advisory data support the merit of establishing a biobank to enable studies of disease risk, provided that health records and research results are adequately protected. The goals of earlier diagnosis and individualized treatment of bipolar disorder were endorsed.

AB - Objectives: The aim of the present study was to engage a national advocacy group and local stakeholders for guidance in developing a bipolar disorder biobank through a web-based survey and a community advisory board. Methods: The Depression and Bipolar Support Alliance and the Mayo Clinic Bipolar Biobank conducted a national web-based survey inquiring about interest in participating in a biobank (i.e., giving DNA and clinical information). A community advisory board was convened to guide establishment of the biobank and identify key deliverables from the research project and for the community. Results: Among 385 survey respondents, funding source (87%), professional opinion (76%), mental health consumer opinion (79%), and return of research results (91%) were believed to be important for considering study participation. Significantly more patients were willing to participate in a biobank managed by a university or clinic (78.2%) than one managed by government (63.4%) or industry (58.2%; both p < 0.001). The nine-member community advisory board expressed interest in research to help predict the likelihood of bipolar disorder developing in a child of an affected parent and which medications to avoid. The advisory board endorsed the use of a comprehension questionnaire to evaluate participants' understanding of the study (e.g., longevity of DNA specimens, right to remove samples, accessing medical records) as a means to strengthen the informed consent process. Conclusions: These national survey and community advisory data support the merit of establishing a biobank to enable studies of disease risk, provided that health records and research results are adequately protected. The goals of earlier diagnosis and individualized treatment of bipolar disorder were endorsed.

KW - Biobank

KW - Bipolar disorder

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=84941026053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941026053&partnerID=8YFLogxK

U2 - 10.1111/bdi.12322

DO - 10.1111/bdi.12322

M3 - Article

C2 - 26291791

AN - SCOPUS:84941026053

VL - 17

SP - 598

EP - 605

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

IS - 6

ER -